Mitochondrial Replacement Techniques: Ethical, Social, and Policy Considerations

Mitochondrial Replacement Techniques: Ethical, Social, and Policy Considerations

Volumn , Issue , 2016, Pages 1-184

  Claiborne, Anne ^a   English, Rebecca ^a   Kahn, Jeffrey ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85010971164     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.17226/21871     Document Type: Book

References (220)

1. FDA (U.S. Food and Drug Administration). 2009. FDA regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps) product list. http://www.fda.gov/Biologics BloodVaccines/TissueTissueProducts/RegulationofTissues/ucm150485.htm (accessed June 19, 2015).
2. FDA Cellular Tissue and Gene Therapies Advisory Committee. 2014. Oocyte modification in assisted reproduction for the prevention of transmission of mitochondrial disease or treatment of infertility. FDA briefing document. http://www.fda.gov/downloads/Advisory Committees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/Cellular TissueandGeneTherapiesAdvisoryCommittee/UCM385461.pdf (accessed December 23, 2015).
3. Filosto, M., M. Mancuso, C. Vives-Bauza, M. R. Vila, S. Shanske, M. Hirano, A. L. Andreu, and S. DiMauro. 2003. Lack of paternal inheritance of muscle mitochondrial DNA in sporadic mitochondrial myopathies. Annals of Neurology 54(4):524-526.
4. Gorman, G. S., A. M. Schaefer, Y. Ng, N. Gomez, E. L. Blakely, C. L. Alston, C. Feeney, R. Horvath, P. Yu-Wai-Man, P. F. Chinnery, R. W. Taylor, D. M. Turnbull, and R. McFarland. 2015. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Annals of Neurology 77(5):753-759.
5. Reddy, P., A. Ocampo, K. Suzuki, J. Luo, S. R. Bacman, S. L. Williams, A. Sugawara, D. Okamura, Y. Tsunekawa, J. Wu, D. Lam, X. Xiong, N. Montserrat, C. Rodriguez Esteban, G. Liu, I. Sancho-Martinez, D. Manau, S. Civico, F. Cardellach, M. del Mar O'Callaghan, J. Campistol, H. Zhao, J. M. Campistol, C. T. Moraes, and J. C. Izpisua Belmonte. 2015. Selective elimination of mitochondrial mutations in the germline by genome editing. Cell 161(3):459-469.
6. Schwartz, M., and J. Vissing. 2002. Paternal inheritance of mitochondrial DNA. New England Journal of Medicine 347(8):576-580.
7. Taylor, R. W., M. T. McDonnell, E. L. Blakely, P. F. Chinnery, G. A. Taylor, N. Howell, M. Zeviani, E. Briem, F. Carrara, and D. M. Turnbull. 2003. Genotypes from patients indicate no paternal mitochondrial DNA contribution. Annals of Neurology 54(4):521-524.
8. Araki, M., and T. Ishii. 2014. International regulatory landscape and integration of corrective genome editing into in vitro fertilization. Reproductive Biology and Endocrinology 12:108.
9. Barritt, J. A., S. Willadsen, C. Brenner, and J. Cohen. 2001a. Cytoplasmic transfer in assisted reproduction. Human Reproduction Update 7(4):428-435.
10. Barritt, J. A., C. A. Brenner, H. E. Malter, and J. Cohen. 2001b. Mitochondria in human offspring derived from ooplasmic transplantation: Brief communication. Human Reproduction 16(3):513-516.
11. Bayona-Bafaluy, M. P., B. Blits, B. J. Battersby, E. A. Shoubridge, and C. T. Moraes. 2005. Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease. Proceedings of the National Academy of Sciences of the United States of America 102(40):14392-14397.
12. Bergthold, L. A. 1995. Medical necessity: Do we need it? Health Affairs 14(4):180-190.
13. Brenner, C. A., J. A. Barritt, S. Willadsen, and J. Cohen. 2000. Mitochondrial DNA heteroplasmy after human ooplasmic transplantation. Fertility and Sterility 74(3):573-578.
14. Brenner, C. A., J. A. Barritt, J. Cohen, and K. E. Pierce. 2001. Quantification of mitochondrial DNA heteroplasmy following ooplasmic transplantation. Human Reproduction 16(Suppl. 1):66-68.
15. Brenner, C. A., H. M. Kubisch, and K. E. Pierce. 2004. Role of the mitochondrial genome in assisted reproductive technologies and embryonic stem cell-based therapeutic cloning. Reproduction, Fertility, and Development 16(7):743-751.
16. Carelli, V., and D. C. Chan. 2014. Mitochondrial DNA: Impacting central and peripheral nervous systems. Neuron 84(6):1126-1142.
17. CDC (U.S. Centers for Disease Control and Prevention), ASRM (American Society for Reproductive Medicine), and SART (Society for Assisted Reproductive Technology). 2015. 2013 Assisted reproductive technology fertility clinic success rates report. Atlanta, GA: CDC.
18. Cohen, J., R. Scott, T. Schimmel, J. Levron, and S. Willadsen. 1997. Birth of infant after transfer of anucleate donor oocyte cytoplasm into recipient eggs. Lancet 350(9072):186-187.
19. Cohen, J., R. Scott, M. Alikani, T. Schimmel, S. Munné, J. Levron, L. Wu, C. Brenner, C. Warner, and S. Willadsen. 1998. Ooplasmic transfer in mature human oocytes. Molecular Human Reproduction 4(3):269-280.
20. Connor, S. 2015. Scientist who pioneered "three-parent" IVF embryo technique now wants to offer it to older women trying for a baby. The Independent, February 8.
21. Council of Europe. 2015. Statement on Genome Editing Technologies. http://www.coe.int/en/ web/bioethics/-/gene-editing?redirect= (accessed December 18, 2015).
22. Craven, L., H. A. Tuppen, G. D. Greggains, S. J. Harbottle, J. L. Murphy, L. M. Cree, A. P. Murdoch, P. F. Chinnery, R. W. Taylor, R. N. Lightowlers, M. Herbert, and D. M. Turnbull. 2010. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 465(7294):82-85.
23. DiMauro, S., and G. Davidzon. 2005. Mitochondrial DNA and disease. Annals of Medicine 37(3):222-232.
24. DiMauro, S., and E. A. Schon. 2003. Mitochondrial respiratory-chain diseases. New England Journal of Medicine 348(26):2656-2668.
25. DiMauro, S., E. A. Schon, V. Carelli, and M. Hirano. 2013. The clinical maze of mitochondrial neurology. Nature Reviews Neurology 9(8):429-444.
26. Elliott, H. R., D. C. Samuels, J. A. Eden, C. L. Relton, and P. F. Chinnery. 2008. Pathogenic mitochondrial DNA mutations are common in the general population. The American Journal of Human Genetics 83(2):254-260.
27. ESHRE (European Society of Human Reproduction and Embryology). 2012. The world's number of IVF and ICSI babies has now reached a calculated total of 5 million. ScienceDaily, July 2. http://www.sciencedaily.com/releases/2012/07/120702134746.htm (accessed December 22, 2015).
28. Eynon, N., M. Moran, R. Birk, and A. Lucia. 2011. The champions' mitochondria: Is it genetically determined? A review on mitochondrial DNA and elite athletic performance. Physiological Genomics 43(13):789-798.
29. FDA (U.S. Food and Drug Administration). 1998a. Establishment registration and listing for manufacturers of human cellular and tissue-based products (21 CFR Parts 207, 807, 1271). Federal Register 63(93):26744-26755.
30. FDA. 1998b. Letter about human cloning, October 26, 1998. http://www.fda.gov/Science Research/SpecialTopics/RunningClinicalTrials/ucm150508.htm (accessed November 9, 2015).
31. FDA. 2001a. Human cells, tissues, and cellular and tissue-based products: Establishment registration and listing. Federal Register 66(13):5447-5469.
32. FDA. 2001b. Letter to sponsors/researchers: Human cells used in therapy involving the transfer of genetic material by means other than the union of gamete nuclei. http://www. fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm105852.htm (accessed January 9, 2015).
33. FDA. 2009. FDA regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps) product list. http://www.fda.gov/BiologicsBloodVaccines/TissueTissueProducts/ RegulationofTissues/ucm150485.htm (accessed November 10, 2015).
34. FDA. 2012. Risk Evaluation and Mitigation Strategy (REMS): The iPLEDGE Program. Single Shared System for Isotretinoin. http://www.fda.gov/downloads/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/UCM234639.pdf (accessed January 9, 2015).
35. FDA. 2014. "Off-label" and investigational use of marketed drugs, biologics, and medical devices-information sheet. http://www.fda.gov/RegulatoryInformation/Guidances/ ucm126486.htm (accessed July 9, 2015).
36. FDA Cellular Tissue and Gene Therapies Advisory Committee. 2014a. Cellular, Tissue and Gene Therapies Advisory Committee Meeting Summary Minutes, February 25, Gaithersburg, MD.
37. FDA Cellular Tissue and Gene Therapies Advisory Committee. 2014b. Oocyte modification in assisted reproduction for the prevention of transmission of mitochondrial disease or treatment of infertility. FDA briefing document. http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/ CellularTissueandGeneTherapiesAdvisoryCommittee/UCM385461.pdf (accessed December 23, 2015).
38. Feeney, C., and R. McFarland. 2014. Complications of pregnancy in patients with mitochondrial disease (observational study). In UK Clinical Research Network Study Portfolio. London, UK: National Institute for Health Research Clinical Research Network Coordinating Centre. http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=12853 (accessed December 23, 2015).
39. Gorman, G. S., J. P. Grady, Y. Ng, A. M. Schaefer, R. J. McNally, P. F. Chinnery, P. Yu-Wai- Man, M. Herbert, R. W. Taylor, R. McFarland, and D. M. Turnbull. 2015a. Mitochondrial donation-how many women could benefit? New England Journal of Medicine 372(9):885-887.
40. Gorman, G. S., A. M. Schaefer, Y. Ng, N. Gomez, E. L. Blakely, C. L. Alston, C. Feeney, R. Horvath, P. Yu-Wai-Man, P. F. Chinnery, R. W. Taylor, D. M. Turnbull, and R. McFarland. 2015b. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Annals of Neurology 77(5):753-759.
41. Handyside, A. H., E. H. Kontogianni, K. Hardy, and R. M. L. Winston. 1990. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature 344(6268):768-770.
42. Heindryckx, B., J. Neupane, M. Vandewoestyne, C. Christodoulou, Y. Jackers, J. Gerris, E. Van den Abbeel, R. Van Coster, D. Deforce, and P. De Sutter. 2014. Mutation-free baby born from a mitochondrial encephalopathy, lactic acidosis and stroke-like syndrome carrier after blastocyst trophectoderm preimplantation genetic diagnosis. Mitochondrion 18:12-17.
43. Houshmand, M., E. Holme, C. Hanson, U.-B. Wennerholm, and L. Hamberger. 1997. Is paternal mitochondrial DNA transferred to the offspring following intracytoplasmic sperm injection? Journal of Assisted Reproduction and Genetics 14(4):223-227.
44. Huang, C. C., T. C. Cheng, H. H. Chang, C. C. Chang, C. I. Chen, J. Liu, and M. S. Lee. 1999. Birth after the injection of sperm and the cytoplasm of tripronucleate zygotes into metaphase II oocytes in patients with repeated implantation failure after assisted fertilization procedures. Fertility and Sterility 72(4):702-706.
45. Hudson, K. L. 2006. Preimplantation genetic diagnosis: Public policy and public attitudes. Fertility and Sterility 85(6):1638-1645.
46. HFEA (Human Fertilisation and Embryology Authority). 2014a. Review of the safety and efficacy of polar body transfer to avoid mitochondrial disease: Addendum to "Third scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception: 2014 update." London, UK: HFEA.
47. HFEA. 2014b. Third scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception: 2014 update. London, UK: HFEA.
48. IBC (International Bioethics Committee). 2015. Report of the IBC on updating its reflection on the human genome and human rights (SHS/YES/IBC-22/15/2 REV.2). Paris, France: United Nations Educational, Scientific and Cultural Organization.
49. Innocenti, P., E. H. Morrow, and D. K. Dowling. 2011. Experimental evidence supports a sexspecific selective sieve in mitochondrial genome evolution. Science 332(6031):845-848.
50. IOM (Institute of Medicine). 2012. Essential health benefits: Balancing coverage and cost. Washington, DC: The National Academies Press.
51. IOM. 2015. Science and Medicine Panel Discussion. Public Workshop of the Committee on Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases, March 31, Washington, DC.
52. Knowles, L. P., and G. E. Kaebnick (Eds.). 2007. Reprogenetics: Law, policy, and ethical issues. Baltimore, MD: The Johns Hopkins University Press.
53. Koga, Y., Y. Akita, J. Nishioka, S. Yatsuga, N. Povalko, Y. Tanabe, S. Fujimoto, and T. Matsuishi. 2005. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 64(4):710-712.
54. Lanzendorf, S. E., J. F. Mayer, J. Toner, S. Oehninger, D. S. Saffan, and S. Muasher. 1999. Pregnancy following transfer of ooplasm from cryopreserved-thawed donor oocytes into recipient oocytes. Fertility and Sterility 71(3):575-577.
55. Lee, H. S., H. Ma, Rita C. Juanes, M. Tachibana, M. Sparman, J. Woodward, C. Ramsey, J. Xu, E.-J. Kang, P. Amato, G. Mair, R. Steinborn, and S. Mitalipov. 2012. Rapid mitochondrial DNA segregation in primate preimplantation embryos precedes somatic and germline bottleneck. Cell Reports 1(5):506-515.
56. Lee, H. Y., J. Y. Chou, L. Cheong, N. H. Chang, S. Y. Yang, and J. Y. Leu. 2008. Incompatibility of nuclear and mitochondrial genomes causes hybrid sterility between two yeast species. Cell 135(6):1065-1073.
57. Liang, P., Y. Xu, X. Zhang, C. Ding, R. Huang, Z. Zhang, J. Lv, X. Xie, Y. Chen, Y. Li, Y. Sun, Y. Bai, Z. Songyang, W. Ma, C. Zhou, and J. Huang. 2015. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein & Cell 6(5):363-372.
58. Marchington, D. R., M. S. Scott Brown, V. K. Lamb, R. J. van Golde, J. A. Kremer, J. H. Tuerlings, E. C. Mariman, A. H. Balen, and J. Poulton. 2002. No evidence for paternal mtDNA transmission to offspring or extra-embryonic tissues after ICSI. Molecular Human Reproduction 8(11):1046-1049.
59. Mishmar, D., E. Ruiz-Pesini, P. Golik, V. Macaulay, A. G. Clark, S. Hosseini, M. Brandon, K. Easley, E. Chen, M. D. Brown, R. I. Sukernik, A. Olckers, and D. C. Wallace. 2003. Natural selection shaped regional mtDNA variation in humans. Proceedings of the National Academy of Sciences of the United States of America 100(1):171-176.
60. Mitalipov, S., P. Amato, S. Parry, and M. J. Falk. 2014. Limitations of preimplantation genetic diagnosis for mitochondrial DNA diseases. Cell Reports 7(4):935-937.
61. Monnot, S., N. Gigarel, D. C. Samuels, P. Burlet, L. Hesters, N. Frydman, R. Frydman, V. Kerbrat, B. Funalot, J. Martinovic, A. Benachi, J. Feingold, A. Munnich, J.-P. Bonnefont, and J. Steffann. 2011. Segregation of mtDNA throughout human embryofetal development: m.3243A >G as a model system. Human Mutation 32(1):116-125.
62. Morrow, E. H., K. Reinhardt, J. N. Wolff, and D. K. Dowling. 2015. Risks inherent to mitochondrial replacement. EMBO Reports 16(5):541-544.
63. Nagy, Z. P., A. C. Varghese, and A. Agarwal (Eds.). 2012. Practical manual of in vitro fertilization: Advanced methods and novel devices. New York: Springer Science+Business Media, LLC.
64. National Commissioning Group (NCG) for Rare Mitochondrial Diseases of Adults and Children (UK). 2013. Newcastle mitochondrial disease guidelines: Pregnancy in mitochondrial disease. http://www.mitochondrialncg.nhs.uk/documents/Pregnancy_Guidelines_% 202011. pdf (accessed December 22, 2015).
65. Neupane, J., M. Vandewoestyne, S. Ghimire, Y. Lu, C. Qian, R. Van Coster, J. Gerris, T. Deroo, D. Deforce, P. De Sutter, and B. Heindryckx. 2014. Assessment of nuclear transfer techniques to prevent the transmission of heritable mitochondrial disorders without compromising embryonic development competence in mice. Mitochondrion 18:27-33.
66. NIH (National Institutes of Health). 2013. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. Bethesda, MD: HHS, NIH, Office of Biotechnology Activities.
67. NIH. 2015. Statement on NIH funding of research using gene-editing technologies in human embryos, edited by F. Collins. http://www.nih.gov/about-nih/who-we-are/ nih-director/statements/statement-nih-funding-research-using-gene-editing-technologies-humanembryos (accessed December 22, 2015).
68. NIH Recombinant DNA Advisory Committee. 1985. Points to consider in the design and submission of human somatic cell gene therapy protocols. Recombinant DNA Technical Bulletin 8(4):181-186.
69. Parikh, S., R. Saneto, M. J. Falk, I. Anselm, B. H. Cohen, and R. Haas. 2009. A modern approach to the treatment of mitochondrial disease. Current Treatment Options in Neurology 11(6):414-430.
70. Parikh, S., A. Goldstein, M. K. Koenig, F. Scaglia, G. M. Enns, and R. Saneto. 2013. Practice patterns of mitochondrial disease physicians in North America. Part 2: Treatment, care and management. Mitochondrion 13(6):681-687.
71. Parikh, S., A. Goldstein, M. K. Koenig, F. Scaglia, G. M. Enns, R. Saneto, I. Anselm, B. H. Cohen, M. J. Falk, C. Greene, A. L. Gropman, R. Haas, M. Hirano, P. Morgan, K. Sims, M. Tarnopolsky, J. L. Van Hove, L. Wolfe, and S. DiMauro. 2014. Diagnosis and management of mitochondrial disease: A consensus statement from the Mitochondrial Medicine Society. Genetics in Medicine 17(9):689-701.
72. Paull, D., V. Emmanuele, K. A. Weiss, N. Treff, L. Stewart, H. Hua, M. Zimmer, D. J. Kahler, R. S. Goland, S. A. Noggle, R. Prosser, M. Hirano, M. V. Sauer, and D. Egli. 2013. Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants. Nature 493(7434):632-637.
73. Pfeffer, G., R. Horvath, T. Klopstock, V. K. Mootha, A. Suomalainen, S. Koene, M. Hirano, M. Zeviani, L. A. Bindoff, P. Yu-Wai-Man, M. Hanna, V. Carelli, R. McFarland, K. Majamaa, D. M. Turnbull, J. Smeitink, and P. F. Chinnery. 2013. New treatments for mitochondrial disease-no time to drop our standards. Nature Reviews: Neurology 9(8):474-481.
74. Price, A. L., N. J. Patterson, R. M. Plenge, M. E. Weinblatt, N. A. Shadick, and D. Reich. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nature Genetics 38(8):904-909.
75. Quijada-Fraile, P., M. O'Callaghan, E. Martin-Hernandez, R. Montero, A. Garcia-Cazorla, A. M. de Aragon, J. Muchart, I. Malaga, R. Pardo, P. Garcia-Gonzalez, C. Jou, J. Montoya, S. Emperador, E. Ruiz-Pesini, J. Arenas, M. A. Martin, A. Ormazabal, M.
76. Pineda, M. T. Garcia-Silva, and R. Artuch. 2014. Follow-up of folinic acid supplementation for patients with cerebral folate deficiency and Kearns-Sayre syndrome. Orphanet Journal of Rare Diseases 9:217.
77. Reddy, P., A. Ocampo, K. Suzuki, J. Luo, S. R. Bacman, S. L. Williams, A. Sugawara, D. Okamura, Y. Tsunekawa, J. Wu, D. Lam, X. Xiong, N. Montserrat, Concepcion R. Esteban, G.-H. Liu, I. Sancho-Martinez, D. Manau, S. Civico, F. Cardellach, M. del Mar O'Callaghan, J. Campistol, H. Zhao, J. M. Campistol, C. T. Moraes, and J. C. Izpisua Belmonte. 2015. Selective elimination of mitochondrial mutations in the germline by genome editing. Cell 161(3):459-469.
78. Reinhardt, K., D. K. Dowling, and E. H. Morrow. 2013. Mitochondrial replacement, evolution, and the clinic. Science 341(6152):1345-1346.
79. Richardson, J., L. Irving, L. A. Hyslop, M. Choudhary, A. Murdoch, D. M. Turnbull, and M. Herbert. 2015. Concise reviews: Assisted reproductive technologies to prevent transmission of mitochondrial DNA disease. Stem Cells 33(3):639-645.
80. Ruiz-Pesini, E., D. Mishmar, M. Brandon, V. Procaccio, and D. C. Wallace. 2004. Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303(5655):223-226.
81. Sallevelt, S. C. E. H., J. C. F. M. Dreesen, M. Drüsedau, S. Spierts, E. Coonen, F. H. J. van Tienen, R. J. T. van Golde, I. F. M. de Coo, J. P. M. Geraedts, C. E. M. de Die- Smulders, and H. J. M. Smeets. 2013. Preimplantation genetic diagnosis in mitochondrial DNA disorders: Challenge and success. Journal of Medical Genetics 50(2):125-132.
82. Samuels, D. C., P. Wonnapinij, and P. F. Chinnery. 2013. Preventing the transmission of pathogenic mitochondrial DNA mutations: Can we achieve long-term benefits from germ-line gene transfer? Human Reproduction (Oxford, England) 28(3):554-559.
83. Saneto, R. P., and M. M. Sedensky. 2013. Mitochondrial disease in childhood: mtDNA encoded. Neurotherapeutics 10(2):199-211.
84. SART (Society for Assisted Reproductive Technology). 2007. Requirements for SART membership. http://www.sart.org/uploadedFiles/Affiliates/SART/Members/Membership%20 Requirements%2007_08.pdf (accessed July 9, 2015).
85. SART. 2008. Revised guidelines for human embryology and andrology laboratories. http:// www.sart.org/uploadedFiles/ASRM_Content/News_and_Publications/Practice: Guidelines/Guidelines_and_Minimum_Standards/Revised_guidelines_for_human(1).pdf (accessed July 9, 2015)
86. SART. 2015. What is SART? http://www.sart.org/What_is_SART (accessed July 9, 2015).
87. SART. 2016. Join SART: Requirements for SART Membership. http://www.sart.org/ membership (accessed January 11, 2016).
88. Sato, A., T. Kono, K. Nakada, K. Ishikawa, S.-I. Inoue, H. Yonekawa, and J.-I. Hayashi. 2005. Gene therapy for progeny of mito-mice carrying pathogenic mtDNA by nuclear transplantation. Proceedings of the National Academy of Sciences of the United States of America 102(46):16765-16770.
89. Say, R. E., R. G. Whittaker, H. E. Turnbull, R. McFarland, R. W. Taylor, and D. M. Turnbull. 2011. Mitochondrial disease in pregnancy: A systematic review. Obstetric Medicine: The Medicine of Pregnancy 4(3):90-94.
90. Schaefer, A. M., R. McFarland, E. L. Blakely, L. He, R. G. Whittaker, R. W. Taylor, P. F. Chinnery, and D. M. Turnbull. 2008. Prevalence of mitochondrial DNA disease in adults. Annals of Neurology 63(1):35-39.
91. Schwartz, M., and J. Vissing. 2002. Paternal inheritance of mitochondrial DNA. New England Journal of Medicine 347(8):576-580.
92. Shoubridge, E. A., and T. Wai. 2007. Mitochondrial DNA and the mammalian oocyte. In Current Topics in Developmental Biology, Vol. 77, edited by G. Schatten and J. St. John. Waltham, MA: Academic Press. Pp. 87-111.
93. Srivastava, S., and C. T. Moraes. 2001. Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease. Human Molecular Genetics 10(26):3093-3099.
94. Steffann, J., N. Frydman, N. Gigarel, P. Burlet, P. F. Ray, R. Fanchin, E. Feyereisen, V. Kerbrat, G. Tachdjian, J. P. Bonnefont, R. Frydman, and A. Munnich. 2006. Analysis of mtDNA variant segregation during early human embryonic development: A tool for successful NARP preimplantation diagnosis. Journal of Medical Genetics 43(3):244-247.
95. Stewart, J. B., C. Freyer, J. L. Elson, and N. G. Larsson. 2008. Purifying selection of mtDNA and its implications for understanding evolution and mitochondrial disease. Nature Reviews Genetics 9(9):657-662.
96. Sutovsky, P., R. D. Moreno, J. Ramalho-Santos, T. Dominko, C. Simerly, and G. Schatten. 1999. Ubiquitin tag for sperm mitochondria. Nature 402(6760):371-372.
97. Tachibana, M., M. Sparman, H. Sritanaudomchai, H. Ma, L. Clepper, J. Woodward, Y. Li, C. Ramsey, O. Kolotushkina, and S. Mitalipov. 2009. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 461(7262):367-372.
98. Tarnopolsky, M. A. 2014. Exercise as a therapeutic strategy for primary mitochondrial cytopathies. Journal of Child Neurology 29(9):1225-1234.
99. Taylor, R. W., and D. M. Turnbull. 2005. Mitochondrial DNA mutations in human disease. Nature Reviews Genetics 6(5):389-402.
100. Treff, N. R., J. Campos, X. Tao, B. Levy, K. M. Ferry, and R. T. Scott, Jr. 2012. Blastocyst preimplantation genetic diagnosis (PGD) of a mitochondrial DNA disorder. Fertility and Sterility 98(5):1236-1240.
101. UK (United Kingdom) Parliament House of Lords. 2015. Human fertilisation and embryology (mitochondrial donation) regulations 2015-motion to approve amendment to the motion. http://www.publications.parliament.uk/pa/ld201415/ldhansrd/text/150224-0002. htm (accessed October 13, 2015).
102. Vafai, S. B., and V. K. Mootha. 2012. Mitochondrial disorders as windows into an ancient organelle. Nature 491(7424):374-383.
103. Viscomi, C., E. Bottani, and M. Zeviani. 2015. Emerging concepts in the therapy of mitochondrial disease. Biochimica et Biophysica Acta (BBA)-Bioenergetics 1847(6-7):544-557.
104. Wallace, D. C. 1994. Mitochondrial DNA sequence variation in human evolution and disease. Proceedings of the National Academy of Sciences of the United States of America 91(19):8739-8746.
105. Wallace, D. C., and D. Chalkia. 2013. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harbor Perspectives in Biology 5(11): a021220.
106. Wang, M. K., D. Y. Chen, J. L. Liu, G. P. Li, and Q. Y. Sun. 2001. In vitro fertilisation of mouse oocytes reconstructed by transfer of metaphase II chromosomes results in live births. Zygote 9(1):9-14.
107. Wang, T., H. Sha, D. Ji, Helen L. Zhang, D. Chen, Y. Cao, and J. Zhu. 2014. Polar body genome transfer for preventing the transmission of inherited mitochondrial diseases. Cell 157(7):1591-1604.
108. Wolf, D. P., N. Mitalipov, and S. Mitalipov. 2015. Mitochondrial replacement therapy in reproductive medicine. Trends in Molecular Medicine 21(2):68-76.
109. Wolff, J. N., E. D. Ladoukakis, J. A. Enríquez, and D. K. Dowling. 2014. Mitonuclear interactions: Evolutionary consequences over multiple biological scales. Philosophical Transactions of the Royal Society B: Biological Sciences 369(1646).
110. Zhang, J., G. Zhuang, Y. Zeng, C. Acosta, Y. Shu, and J. Grifo. 2003. Pregnancy derived from human nuclear transfer. Fertility and Sterility 80:56.
111. AAAS (American Association for the Advancement of Science). 2000. Human inheritable genetic modifications: Assessing scientific, ethical, religious, and policy issues. http://www. aaas.org/sites/default/files/migrate/uploads/germline.pdf (accessed December 6, 2015).
112. Adams, M. B. 1990. The wellborn science: Eugenics in Germany, France, Brazil, and Russia. New York: Oxford University Press.
113. Allen, G. E. 2002. The ideology of elimination: American and German eugenics, 1900-1945. In Medicine and Medical Ethics in Nazi Germany: Origins, Practices, Legacies, edited by F. R. Nicosia and J. Heuner. New York: Berghahn Books. Pp. 13-39.
114. Asch, A. 1989. "Reproductive Technology and Disability." In Reproductive Laws for the 1990s, edited by S. Cohen and N. Taub. Clifton, NJ: Humana Press. Pp. 69-124.
115. Bacchetta, M. D., and G. Richter. 1996. Response to "Germ-line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation" by Donald Rubenstein, David C. Thomasma, Eric A. Schon, and Michael J. Zinaman. Cambridge Quarterly of Healthcare Ethics 5(3):450-457.
116. Baylis, F. E. 1990. The ethics of ex utero research on spare "non-viable" IVF human embryos. Bioethics 4(4):311-329.
117. Baylis, F. 2013. The ethics of creating children with three genetic parents. Reproductive Biomedicine Online 26:531-534.
118. Bell, A. V. 2009. "It's way out of my league": Low-income women's experiences of medicalized infertility. Gender & Society 23(5):688-709.
119. Board of the Council for Responsible Genetics. 2000. The Genetic Bill of Rights. http://www. councilforresponsiblegenetics.org/Projects/CurrentProject.aspx?projectId=5 (accessed December 28, 2015).
120. Bonnicksen, A. L. 1998. Transplanting nuclei between human eggs: Implications for germ-line genetics. Politics and the Life Sciences 17(1):3-10.
121. Bredenoord, A. L., G. Pennings, and G. de Wert. 2008. Ooplasmic and nuclear transfer to prevent mitochondrial DNA disorders: conceptual and normative issues. Human Reproduction Update 14(6):669-678.
122. Catholic Church. 2003. Catechism of the Catholic Church, 2nd ed., revised in accordance with the official Latin text promulgated by Pope John Paul II. Vatican City: Libreria Editrice Vaticana.
123. Chapman, A. R., and M. S. Frankel. 2003. Designing our descendants: The promises and perils of genetic modifications. Baltimore, MD: The Johns Hopkins University Press.
124. Collishaw, S., B. Maughan, and A. Pickles. 1998. Infant adoption: Psychosocial outcomes in adulthood. Social Psychiatry and Psychiatric Epidemiology 33(2):57-65.
125. Connor, S. 2015. Scientist who pioneered "three-parent" IVF embryo technique now wants to offer it to older women trying for a baby. The Independent, February 8.
126. Cotton, R. G. H. 2007. Recommendations of the 2006 Human Variome Project meeting. Nature Genetics 39(4):433-436.
127. Darnovsky, M. 2015. Presentation to the March 31-April 1 Public Workshop of the Committee on Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases, Washington, DC. http:// iom.nationalacademies.org/Activities/Research/MitoEthics/2015-MAR-31.aspx (accessed August 26, 2015).
128. Department of Health & Social Security (United Kingdom). 1984. Report of the Committee of Inquiry into Human Fertilisation and Embryology (The Warnock Report). London, UK: Her Majesty's Stationery Office.
129. Department of Health Education and Welfare Ethics Advisory Board. 1979. HEW support of research involving human in vitro fertilization and embryo transfer. Washington, DC: U.S. Government Printing Office.
130. Dorff, E. N., and L. Zoloth. 2015. Jews and genes: The genetics future in contemporary Jewish thought. Philadelphia, PA: The Jewish Publication Society.
131. Engelstad, K., M. Sklerov, J. Kriger, A. Sanford, J. Grier, D. Ash, D. Egli, S. DiMauro, J. L. P. Thompson, M. Sauer, and M. Hirano. Submitted. Attitudes towards prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy.
132. Evans, J. H. 2010. Contested reproduction: Genetic technologies, religion, and public debate. Chicago, IL, and London, UK: University of Chicago Press.
133. Falk, M. J. 2010. Neurodevelopmental manifestations of mitochondrial disease. Journal of Developmental and Behavioral Pediatrics 31(7):610-621.
134. Gavrilov, S., R. W. Prosser, I. Khalid, J. MacDonald, M. V. Sauer, D. W. Landry, and V. E. Papaioannou. 2009. Non-viable human embryos as a source of viable cells for embryonic stem cell derivation. Reproductive Biomedicine Online 18(2):301-308.
135. George, R. P., and P. Lee. 2009. Embryonic human persons: Talking point on morality and human embryo research. EMBO Reports 10(4):301-306.
136. Gorman, G. S., J. P. Grady, Y. Ng, A. M. Schaefer, R. J. McNally, P. F. Chinnery, P. Yu-Wai-Man, M. Herbert, R. W. Taylor, R. McFarland, and D. M. Turnbull. 2015. Mitochondrial donation-how many women could benefit? New England Journal of Medicine 372(9):885-887.
137. Heijkoop, M., J. Semon Dubas, and M. A. G. van Aken. 2009. Parent-child resemblance and kin investment: Physical resemblance or personality similarity? European Journal of Developmental Psychology 6(1):64-69.
138. Hewitt, G. 2002. Missing links: Identity issues of donor conceived people. Journal of Fertility Counselling 9(3):14-20.
139. Kevles, D. J. 1985. In the name of eugenics: Genetics and the uses of human heredity. New York: Alfred A. Knopf.
140. Kevles, D. J. 1992. Out of Eugenics. In The Code of codes: Scientific and social issues in the Human Genome Project, edited by D. J. Kevles and L. E. Hood. Cambridge, MA: Harvard University Press.
141. Kirkman, M. 2003. Parents' contributions to the narrative identity of offspring of donorassisted conception. Social Science and Medicine 57(11):2229-2242.
142. Kirkman, M. 2008. Being a "real" mum: Motherhood through donated eggs and embryos. Women's Studies International Forum 31(4):241-248.
143. Klitzman, R., M. Toynbee, and M. V. Sauer. 2015. Controversies concerning mitochondrial replacement therapy. Fertility and Sterility 103(2):344-346.
144. Larson, E. J. 1995. Sex, race, and science: Eugenics in the deep South. Baltimore, MD: The Johns Hopkins University Press.
145. Lindee, M. S. 2005. Moments of truth in genetic medicine. Baltimore, MD: The Johns Hopkins University Press.
146. Lomax, G. P., and A. O. Trounson. 2013. Correcting misperceptions about cryopreserved embryos and stem cell research. Nature Biotechnology 31(4):288-290.
147. Lombardo, P. A. 2003. Taking eugenics seriously. In Florida State University Law Review. Vol. 30. Tallahassee: Florida State University College of Law. Pp. 191-218.
148. Loomans, M. 2013. Do evolutionary mechanisms apply for adoptive families? The link between physical resemblance, personality similarity and odor recognition on the parentchild relationship in adoptive families. Utrecht, Netherlands: University Utrecht.
149. Lustig, B. A., B. A. Brody, and G. P. McKenny (Eds.). 2008. Altering nature. Volume II: Religion, biotechnology, and public policy. New York: Springer.
150. Mahlstedt, P. P., K. LaBounty, and W. T. Kennedy. 2010. The views of adult offspring of sperm donation: Essential feedback for the development of ethical guidelines within the practice of assisted reproductive technology in the United States. Fertility and Sterility 93(7):2236-2246.
151. McKusick, V. A. 2007. Mendelian inheritance in man and its online version, OMIM. American Journal of Human Genetics 80(4):588-604.
152. Neville, M. 2015. Why a Generation of Adoptees Is Returning to South Korea. New York Times Magazine, http://www.nytimes.com/2015/01/18/magazine/why-a-generation-ofadoptees- is-returning-to-south-korea.html?_r=1 (accessed December 7, 2015).
153. NIH (National Institutes of Health) Human Embryo Research Panel. 1994. Report of the Human Embryo Research Panel (Vol. 1). Bethesda, MD: NIH.
154. Noonan, J. T. 1970. The morality of abortion: Legal and historical perspectives. Cambridge, MA: Harvard University Press.
155. Nuffield Council on Bioethics. 2012. Novel techniques for the prevention of mitochondrial DNA disorders: An ethical review. http://nuffieldbioethics.org/wp-content/uploads/| 2014/06/Novel_techniques_for_the_prevention_of_mitochondrial_DNA_disorders_ compressed.pdf (accessed December 28, 2015).
156. Parens, E., and A. Asch. 1999. Special Supplement: The Disability Rights Critique of Prenatal Genetic Testing Reflections and Recommendations. The Hastings Center Report 29(5):S1-S22.
157. Paul, D. B. 1995. Controlling human heredity: 1865 to the present. Atlantic Highlands, NJ: Humanities Press International.
158. Pfleiderer, G., G. Brahier, and K. Lindpaintner (Eds.). 2010. GenEthics and religion. Basel, Switzerland: Karger.
159. Pine, S. 2015. Please don't tell me I was lucky to be adopted. Washington Post Magazine. https://www.washingtonpost.com/lifestyle/magazine/please-dont-tell-me-i-was-lucky-tobe- adopted/2014/12/31/9e9e9472-6f48-11e4-ad12-3734c461eab6_story.html (accessed January 9, 2015).
160. Plomin, R., D. W. Fulker, R. Corley, and J. C. DeFries. 1997. Nature, nurture, and cognitive development from 1 to 16 years: A parent-offspring adoption study. Psychological Science 8(6):442-447.
161. Rapp, R. 2000. Testing women, testing the fetus: The social impact of amniocentesis in America. New York; London: Routledge.
162. Ravin, A. J., M. B. Mahowald, and C. B. Stocking. 1997. Genes or gestation?: Attitudes of women and men about biologic ties to children. Journal of Women's Health 6(6):639-647.
163. Reilly, P. 1991. The surgical solution: A history of involuntary sterilization in the United States. Baltimore, MD: The Johns Hopkins University Press.
164. Robertson, J. A. 1988. Procreative liberty, embryos, and collaborative reproduction. Women & Health 13(1-2):179-194.
165. Royal College of Obstetricians and Gynaecologists Ethics Committee. 1983. Report of the Royal College of Obstetricians and Gynaecologists Ethics Committee on in vitro fertilisation and embryo replacement. London, UK: Royal College of Obstetricians and Gynaecologists.
166. Sandel, M. J. 2004. Embryo ethics-the moral logic of stem-cell research. New England Journal of Medicine 351(3):207-209.
167. Sanner, M. A. 2001. Exchanging spare parts or becoming a new person? People's attitudes toward receiving and donating organs. Social Science and Medicine 52(10):1491-1499.
168. Sanner, M. A. 2003. Transplant recipients' conceptions of three key phenomena in transplantation: The organ donation, the organ donor, and the organ transplant. Clinical Transplantation 17(4):391-400.
169. Sault, N. L. 1996. Many mothers, many fathers: The meaning of parenting around the world. Santa Clara Law Review 36(7):395-408.
170. Schoen, J. 2005. Choice & coercion: Birth control, sterilization, and abortion in public health and welfare. Chapel Hill: University of North Carolina Press.
171. Sharp, L. A. 1995. Organ transplantation as a transformative experience: Anthropological insights into the restructuring of the self. Medical Anthropology Quarterly 9(3):357-389.
172. Smyer, M. A., M. Gatz, N. L. Simi, and N. L. Pedersen. 1998. Childhood adoption: Long-term effects in adulthood. Psychiatry 61(3):191-205.
173. Snow, D., A. Cattapan, and F. Baylis. 2015. Contesting estimates of cryopreserved embryos in the United States. Nature Biotechnology 33(9):909.
174. Stenson, P. D., M. Mort, E. V. Ball, K. Howells, A. D. Phillips, N. S. T. Thomas, and D. N. Cooper. 2009. The Human Gene Mutation Database: 2008 update. Genome Medicine 1(1):13.1-13.6.
175. Suzuki, D. T., and P. Knudtson. 1990. Genethics: The ethics of engineering life. London, UK: Unwin Paperbacks.
176. Swedish National Council on Medical Ethics. 2013. Mitochondria replacement in cases of serious diseases-ethical aspects 2013:2 (Summary of the original report "Mitokondriebyte vid allvarlig sjukdom-etiska aspekter, 2013:2). http://www.smer.se/opinions/ mitochondrial-replacement-in-cases-of-serious-diseases-ethical-aspects-20132 (accessed February 18, 2016).
177. Thornton, J. G., H. M. McNamara, and I. A. Montague. 1994. Would you rather be a "birth" or a "genetic" mother? If so, how much? Journal of Medical Ethics 20(2):87-92.
178. Tingley, K. 2014. The brave new world of three-parent I.V.F. The New York Times, June 27.
179. Turner, A. J., and A. Coyle. 2000. What does it mean to be a donor offspring? The identity experiences of adults conceived by donor insemination and the implications for counselling and therapy. Human Reproduction 15(9):2041-2051.
180. UNESCO (United Nations Educational, Scientific and Cultural Organization). 2005. Universal Declaration on Bioethics and Human Rights. Paris, France: UNESCO.
181. van den Akker, O. 2000. The importance of a genetic link in mothers commissioning a surrogate baby in the UK. Human Reproduction 15(8):1849-1855.
182. Aldoory, L., K. E. B. Ryan, and A. M. Rouhani. 2014. Best practices and new models of health literacy for informed consent: Review of the impact of informed consent regulations on health literate communications. http://iom.nationalacademies.org/Activities/Public Health/HealthLiteracy/~/media/Files/Activity%20Files/PublicHealth/HealthLiteracy/ Commissioned-Papers/Informed_Consent_HealthLit.pdf (accessed September 27, 2015).
183. Appleby, J. B. 2015. The ethical challenges of the clinical introduction of mitochondrial replacement techniques. Medical, Health Care, and Philosophy 18(4):501-514.
184. ASRM (American Society for Reproductive Medicine). 2007. Financial compensation of oocyte donors. Fertility and Sterility 88(2):305-309.
185. Baylis, F. 2013. The ethics of creating children with three genetic parents. Reproductive Bio- Medicine Online 26(6):531-534.
186. Bonnicksen, A. 1998. Transplanting nuclei between human eggs: Implications for germ-line genetics. Politics and the Life Sciences 17(1):3-10.
187. Bredenoord, A. L., W. Dondorp, G. Pennings, and G. De Wert. 2010. Avoiding transgenerational risks of mitochondrial DNA disorders: a morally acceptable reason for sex selection? Human Reproduction 25(6):1354-1360.
188. CDC (U.S. Centers for Disease Control and Prevention), ASRM, and SART (Society for Assisted Reproductive Technology). 2015. 2013 Assisted reproductive technology fertility clinic success rates report. Atlanta, GA: CDC.
189. Darnovsky, M. 2015. Comments by Marcy Darnovsky, Ph.D., Executive Director, Center for Genetics and Society. Public Workshop of the Committee on Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases, March 31, Washington, DC.
190. Egli, D., A. E. Chen, G. Saphier, D. Powers, M. Alper, K. Katz, B. Berger, R. Goland, R. L. Leibel, D. A. Melton, and K. Eggan. 2011. Impracticality of egg donor recruitment in the absence of compensation. Cell Stem Cell 9(4):293-294.
191. FDA (U.S. Food and Drug Administration) Cellular Tissue and Gene Therapies Advisory Committee. 2014. Cellular, Tissue and Gene Therapies Advisory Committee Meeting Summary Minutes, February 25, Gaithersburg, MD.
192. FDA Center for Biologics Evaluation and Research. 2013. Guidance for industry: Preclinical assessment of investigational cellular and gene therapy products. http://www.fda.gov/ BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Cellular andGeneTherapy/ucm376136.htm (accessed August 26, 2015).
193. FDA Center for Biologics Evaluation and Research. 2015. Guidance for industry: Considerations for the design of early-phase clinical trials of cellular and gene therapy products. http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatory Information/Guidances/CellularandGeneTherapy/UCM359073.pdf (accessed January 8, 2016).
194. Fitzgerald, K. 2015. Ethical and social implications of MRT. Presentation to the March 31-April 1 Public Workshop of the Committee on Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases, Washington, DC. http://iom.nationalacademies.org/Activities/Research/ MitoEthics/2015-MAR-31.aspx (accessed August 26, 2015).
195. Grant, R. W., and J. Sugarman. 2004. Ethics in human subjects research: Do incentives matter? The Journal of Medicine and Philosophy 29(6):717-738.
196. Haimes, E., L. Skene, A. J. Ballantyne, T. Caulfield, L. S. Goldstein, I. Hyun, J. Kimmelman, J. S. Robert, B. E. Roxland, C. T. Scott, J. H. Solbakk, J. Sugarman, P. L. Taylor, and G. Testa. 2013. ISSCR Committee Forum: Position statement on the provision and procurement of human eggs for stem cell research. Cell Stem Cell 12(3):285-291.
197. HFEA (Human Fertilisation and Embryology Authority). 2015. Regulating mitochondrial donation: Seeking expert views. London, UK: HFEA.
198. IOM (Institute of Medicine). 2008. The National Children's Study research plan: A review. Washington, DC: The National Academies Press.
199. IOM. 2013. The California Institute for Regenerative Medicine: Science, governance, and the pursuit of cures. Washington, DC: The National Academies Press.
200. IOM. 2015. Science and Medicine Panel Discussion. Public Workshop of the Committee on Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases, March 31, Washington, DC.
201. IOM and NRC (National Research Council). 2007. Assessing the medical risks of human oocyte donation for stem cell research: Workshop report. Washington, DC: The National Academies Press.
202. Kalfoglou, A. L., T. Doksum, B. Bernhardt, G. Geller, L. LeRoy, D. J. H. Mathews, J. H. Evans, D. J. Doukas, N. Reame, J. Scott, and K. Hudson. 2005a. Opinions about new reproductive genetic technologies: Hopes and fears for our genetic future. Fertility and Sterility 83(6):1612-1621.
203. Kalfoglou, A. L., J. Scott, and K. Hudson. 2005b. PGD patients' and providers' attitudes to the use and regulation of preimplantation genetic diagnosis. Reproductive Biomedicine Online 11(4):486-496.
204. Liang, W. 2015. Mitochondrial manipulation technologies: Preclinical considerations. Presentation to the March 31-April 1 Public Workshop of the Committee on Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases, Washington, DC. http://iom.nationalacademies.org/Activities/ Research/MitoEthics/2015-MAR-31.aspx (accessed August 26, 2015).
205. Lo, B., and L. Parham. 2009. Ethical issues in stem cell research. Endocrine Reviews 30(3): 204-213.
206. Lomax, G. P., Z. W. Hall, and B. Lo. 2007. Responsible oversight of human stem cell research. The California Institute for Regenerative Medicine's Medical and Ethical Standards. PLoS Medicine 4(5):e114.
207. Magnus, D., and M. K. Cho. 2005. Issues in oocyte donation for stem cell research. Science. 308(5729):1747-1748. http://www.sciencemag.org/content/308/5729/1747.long (accessed December 6, 2015).
208. McGowan, M. L., C. Burant, R. Moran, and R. Farrell. 2009. Patient education and informed consent for preimplantation genetic diagnosis: Health literacy for genetics and assisted reproductive technology. Genetics in Medicine 11(9):640-645.
209. NIH (National Institutes of Health). 2009. National Institutes of Health guidelines for human stem cell research. Bethesda, MD: NIH.
210. NRC (National Research Council) and IOM. 2010. Final report of the National Academies' Human Embryonic Stem Cell Research Advisory Committee and 2010 amendments to the National Academies' guidelines for human embryonic stem cell research. Washington, DC: The National Academies Press.
211. Nuffield Council on Bioethics. 2012. Novel techniques for the prevention of mitochondrial DNA disorders: An ethical review. http://nuffieldbioethics.org/wp-content/uploads/2014/06/ Novel_techniques_for_the_prevention_of_mitochondrial_DNA_disorders_ compressed.pdf (accessed December 28, 2015).
212. Presidential Commission for the Study of Bioethical Issues. 2013. Anticipate and communicate: Ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts. http://bioethics.gov/sites/default/files/FINALAnticipate Communicate_PCSBI_0.pdf (accessed December 28, 2015).
213. Tachibana, M., M. Sparman, H. Sritanaudomchai, H. Ma, L. Clepper, J. Woodward, Y. Li, C. Ramsey, O. Kolotushkina, and S. Mitalipov. 2009. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 461(7262):367-372.
214. Zoloth, L. 2015. Ethical and social implications of MRT. Presentation to the March 31-April 1 Public Workshop of the Committee on Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases, Washington, DC. http://iom.nationalacademies.org/Activities/Research/MitoEthics/2015- MAR-31.aspx (accessed August 26, 2015).
215. HFEA (Human Fertilisation and Embryology Authority). 2014. Third scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception: 2014 update. London, UK: HFEA.
216. McGrath, J., and D. Solter. 1983. Nuclear transplantation in the mouse embryo by microsurgery and cell fusion. Science 220(4603):1300-1302.
217. Neupane, J., M. Vandewoestyne, S. Ghimire, Y. Lu, C. Qian, R. Van Coster, J. Gerris, T. Deroo, D. Deforce, P. De Sutter, and B. Heindryckx. 2014. Assessment of nuclear transfer techniques to prevent the transmission of heritable mitochondrial disorders without compromising embryonic development competence in mice. Mitochondrion 18:27-33.
218. Sato, A., T. Kono, K. Nakada, K. Ishikawa, S.-I. Inoue, H. Yonekawa, and J.-I. Hayashi. 2005. Gene therapy for progeny of mito-mice carrying pathogenic mtDNA by nuclear transplantation. Proceedings of the National Academy of Sciences of the United States of America 102(46):16765-16770.
219. Tachibana, M., M. Sparman, H. Sritanaudomchai, H. Ma, L. Clepper, J. Woodward, Y. Li, C. Ramsey, O. Kolotushkina, and S. Mitalipov. 2009. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 461(7262):367-372.
220. Tachibana, M., P. Amato, M. Sparman, J. Woodward, D. M. Sanchis, H. Ma, N. M. Gutierrez, R. Tippner-Hedges, E. Kang, H.-S. Lee, C. Ramsey, K. Masterson, D. Battaglia, D. Lee, D. Wu, J. Jensen, P. Patton, S. Gokhale, R. Stouffer, and S. Mitalipov. 2013. Towards germline gene therapy of inherited mitochondrial diseases. Nature 493(7434):627-631.